Position in LLY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,414,896
+$1,470,273 QoQ
Shares Held
4,800
+75.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2.1875.ToString("F0")%
Shared 0.ToString("F0")%
None 97.8125.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026LOOMIS SAYLES & CO L P holds $1,490,658,820 across 10 Drug Manufacturers - General names. LLY ranks #7 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
5,426,100 | $828,836,774 | |
| 2 | NVO |
Novo Nordisk A S
|
17,017,315 | $625,386,326 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
158,632 | $9,621,030 | |
| 4 | MRK |
Merck & Co., Inc.
|
74,671 | $8,982,174 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
46,065 | $6,420,078 | |
| 6 | ABBV |
AbbVie Inc.
|
26,603 | $5,785,886 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
4,800 | $4,414,896 | |
| 8 | JNJ |
Johnson & Johnson
|
2,983 | $729,164 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,414,896 | 4,800 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,944,623 | 2,740 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,326,094 | 1,738 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,352,484 | 1,735 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,756,710 | 2,127 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,719,244 | 2,227 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,655,821 | 1,869 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,357,164 | 1,499 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $986,453 | 1,268 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $597,493 | 1,025 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $574,191 | 1,069 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $118,182 | 252 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $91,693 | 267 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $43,900 | 120 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $28,131 | 87 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $28,856 | 89 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $26,632 | 93 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $41,709 | 151 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $49,213 | 213 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $38,788 | 169 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $30,451 | 163 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,540,664 | 9,125 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,025,777 | 6,930 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,166,169 | 7,103 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,103,378 | 7,954 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||